Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / TARS - Tarsus Pharmaceuticals files for up to $300M mixed shelf offering


TARS - Tarsus Pharmaceuticals files for up to $300M mixed shelf offering

Tarsus Pharmaceuticals (NASDAQ:TARS) has filed for an up to $300M mixed shelf offering. The filing does not necessarily indicate that a sale has begun, or will occur in the future. Find out more about phase 2b/3 results presented on the company's lead candidate, TP-03 (lotilaner ophthalmic solution, 0.25%) for the treatment of Demodex blepharitis.

For further details see:

Tarsus Pharmaceuticals files for up to $300M mixed shelf offering
Stock Information

Company Name: Tarsus Pharmaceuticals Inc.
Stock Symbol: TARS
Market: NASDAQ
Website: tarsusrx.com

Menu

TARS TARS Quote TARS Short TARS News TARS Articles TARS Message Board
Get TARS Alerts

News, Short Squeeze, Breakout and More Instantly...